Wird geladen...
Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders
BACKGROUND: Intravenous immunoglobulin (IVIg) treatment partially replaces antibody defects and modulates innate and adaptive immune cells in patients with primary antibody deficiencies. MATERIALS AND METHODS: This study was focused on the evaluation of the effects of in vivo IVIg administration on...
Gespeichert in:
| Veröffentlicht in: | Blood Transfus |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Edizioni SIMTI - SIMTI Servizi Srl
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6476744/ https://ncbi.nlm.nih.gov/pubmed/30036181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2018.0043-18 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|